These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37261364)

  • 1. Atazanavir-induced unconjugated hyperbilirubinemia prevents vascular hyporeactivity during experimental human endotoxemia.
    Dorresteijn MJ; Dekker D; Zwaag J; Heemskerk S; Roelofs HMJ; Smits P; van der Hoeven JG; Wagener FADTG; Pickkers P
    Front Immunol; 2023; 14():1176775. PubMed ID: 37261364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
    Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
    Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.
    Roy-Chowdhury J; Roy-Chowdhury N; Listowsky I; Wolkoff AW
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):140-146. PubMed ID: 28263463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
    Li M; Chan WW; Zucker SD
    J Am Heart Assoc; 2020 Oct; 9(19):e016310. PubMed ID: 32930032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: fasting increases serum concentrations of bilirubin in patients receiving atazanavir: results from a pilot study.
    Lopardo G; Bissio E; Espinola L; Gallego P; Stambullian M; Gadano A
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):456-60. PubMed ID: 23113663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.
    Johnson DH; Venuto C; Ritchie MD; Morse GD; Daar ES; McLaren PJ; Haas DW
    Pharmacogenet Genomics; 2014 Apr; 24(4):195-203. PubMed ID: 24557078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of atazanavir-ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics.
    Moyle G; Else L; Jackson A; Back D; Yapa MH; Seymour N; Ringner-Nackter L; Karolia Z; Gazzard B; Boffito M
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3640-4. PubMed ID: 23689708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin.
    McCarty MF
    Med Hypotheses; 2007; 69(5):974-94. PubMed ID: 17825497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
    Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
    J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm.
    Pleiner J; Mittermayer F; Schaller G; MacAllister RJ; Wolzt M
    Circulation; 2002 Sep; 106(12):1460-4. PubMed ID: 12234948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia.
    Kadl A; Pontiller J; Exner M; Leitinger N
    Shock; 2007 Nov; 28(5):582-8. PubMed ID: 17577133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
    Culley CL; Kiang TK; Gilchrist SE; Ensom MH
    Ann Pharmacother; 2013 Apr; 47(4):561-72. PubMed ID: 23548653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The α7-nAChR/heme oxygenase-1/carbon monoxide pathway mediates the nicotine counteraction of renal inflammation and vasoconstrictor hyporeactivity in endotoxic male rats.
    Wedn AM; El-Gowilly SM; El-Mas MM
    Inflamm Res; 2020 Feb; 69(2):217-231. PubMed ID: 31897506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus.
    Dekker D; Dorresteijn MJ; Pijnenburg M; Heemskerk S; Rasing-Hoogveld A; Burger DM; Wagener FA; Smits P
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):458-63. PubMed ID: 21088253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole augments the antiinflammatory response during human endotoxemia.
    Ramakers BP; Riksen NP; Stal TH; Heemskerk S; van den Broek P; Peters WH; van der Hoeven JG; Smits P; Pickkers P
    Crit Care; 2011; 15(6):R289. PubMed ID: 22129171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
    Martin DE; Galbraith H; Schettler J; Ellis C; Doto J
    Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.
    Milian J; Goldfine AB; Zuflacht JP; Parmer C; Beckman JA
    Acta Diabetol; 2015 Aug; 52(4):709-15. PubMed ID: 25563478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction.
    Liu XM; Durante ZE; Peyton KJ; Durante W
    Free Radic Biol Med; 2016 May; 94():218-29. PubMed ID: 26968795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin prevents vascular hyporeactivity during inflammation.
    Pleiner J; Schaller G; Mittermayer F; Zorn S; Marsik C; Polterauer S; Kapiotis S; Wolzt M
    Circulation; 2004 Nov; 110(21):3349-54. PubMed ID: 15520323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.